MedNous | Business of medical innovation

Evernow Publishing Ltd Privacy Policy. Read more.

Free featured article

Roche lifts sales by 7% at nine months

Country

Switzerland

The Roche group reported sales of CHF 42.1 billion ($42.5 billion) for the first nine months of 2018, up by 7% from a year earlier led by strong demand in the US for its cancer medicines and a new multiple sclerosis drug. The Switzerland-based company does not provide earnings figures for the third quarter.

Nevertheless it is forecasting a further increase in its dividend in Swiss francs for the year. In 2017, the company paid a dividend of CHF 8.30 per share.

Parker Institute invests in new CAR T cell platform

Country

United States

The Parker Institute for Cancer Immunotherapy has invested in a chimeric antigen receptor T cell technology developed by Xyphos Biosciences Inc of South San Francisco, US which claims the platform is safer and more effective than existing approaches. Financial terms of the collaboration were not disclosed.

Amgen takes equity stake in Oxford Nanopore

Country

United States

Amgen Inc has made a £50 million equity investment in Oxford Nanopore Technologies Ltd of the UK as part of its strategy of using genetic data to develop new medicines. Amgen’s subsidiary deCODE Genetics of Iceland currently uses Oxford Nanopore’s sequencing technologies to conduct genome research including the identification and validation of new drug targets.